Platform / AI oncology imaging diagnostics
Lunit
Lunit (founded 2013, KOSDAQ: KQ 328130) is a Seoul AI oncology diagnostics company whose SCOPE IO and SCOPE PD-L1 use deep-learning to predict cancer biomarkers from histopathology slides; Lunit INSIGHT covers chest X-ray, mammography, and PET-CT. FDA 510(k) cleared, CE marked, MFDS approved. USD 175M raised.
Relationships
SoftBank Ventures, Kakao Ventures, Hanwha Asset Management
Key people
- Brandon Suh (CEO and Co-Founder); Dr. Sung Yoon Lim (Chief Medical Officer)